Last reviewed · How we verify

NCT03708185: BEAST

Beta-alanine Supplementation and High-intensity Interval Training

Completed NA Last updated 30 September 2021
What this trial tests

NA trial testing Beta-alanine in Healthy in 26 participants. Completed in 28 June 2021.

Timeline
4 June 2018
Primary endpoint
20 December 2019
28 June 2021

Quick facts

Lead sponsorUniversity of Exeter
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment26
Start date4 June 2018
Primary completion20 December 2019
Estimated completion28 June 2021
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

University of Exeter

Who can join

Adults 18 to 50, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study will seek to quantify whether a period of HIIT alongside β-alanine supplementation will improve the adaptation to training, and therefore performance, more than a period of HIIT alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Beta-alanine

Trials testing the same drug.

Other recruiting trials for Healthy

Currently open trials in the same condition.

Other University of Exeter trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03708185.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing